Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Psychosocial, educational, and somatic factors in chronic nonspecific low back pain.

Vereckei E, Susanszky E, Kopp M, Ratko I, Czimbalmos A, Nagy Z, Palkonyai E, Hodinka L, Temesvari PI, Kiss E, Töro K, Poor G.

Rheumatol Int. 2013 Mar;33(3):587-92. doi: 10.1007/s00296-012-2398-0. Epub 2012 Apr 3. Erratum in: Rheumatol Int. 2013 Aug;33(8):2187. multiple author names corrected.

PMID:
22476243
2.

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.

Baranauskaite A, Raffayová H, Kungurov NV, Kubanova A, Venalis A, Helmle L, Srinivasan S, Nasonov E, Vastesaeger N; RESPOND investigators.

Ann Rheum Dis. 2012 Apr;71(4):541-8. doi: 10.1136/ard.2011.152223. Epub 2011 Oct 12.

3.

Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.

Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, Horváth G, Koó E, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L.

Scand J Rheumatol. 2010 Aug;39(4):303-9. doi: 10.3109/03009740903468982.

PMID:
20166848
4.
5.

Back pain and sacroiliitis in long-standing adult celiac disease: a cross-sectional and follow-up study.

Vereckei E, Mester A, Hodinka L, Temesvári P, Kiss E, Poór G.

Rheumatol Int. 2010 Feb;30(4):455-60. doi: 10.1007/s00296-009-0979-3. Epub 2009 Jun 6.

PMID:
19504097
6.

Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment.

Brodszky V, Bálint P, Géher P, Hodinka L, Horváth G, Koó É, Péntek M, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L.

Rheumatol Int. 2009 Dec;30(2):199-205. doi: 10.1007/s00296-009-0936-1.

PMID:
19381635
7.

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Keystone EC, Genovese MC, Klareskog L, Hsia EC, Hall ST, Miranda PC, Pazdur J, Bae SC, Palmer W, Zrubek J, Wiekowski M, Visvanathan S, Wu Z, Rahman MU; GO-FORWARD Study.

Ann Rheum Dis. 2009 Jun;68(6):789-96. doi: 10.1136/ard.2008.099010. Epub 2008 Dec 9. Erratum in: Ann Rheum Dis. 2011 Jan;70(1):238.

8.

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, Woodworth T, Alten R; OPTION Investigators.

Lancet. 2008 Mar 22;371(9617):987-97. doi: 10.1016/S0140-6736(08)60453-5.

PMID:
18358926
9.

[Rituximab in patients with rheumatoid arthritis: systematic review].

Brodszky V, Czirják L, Géher P, Hodinka L, Kárpáti K, Péntek M, Poór G, Szekanecz Z, Gulácsi L.

Orv Hetil. 2007 Oct 7;148(40):1883-93. Review. Hungarian.

PMID:
17905683
10.

HLA-DR genotypes in familial rheumatoid arthritis: increased frequency of protective and neutral alleles in a multicase family.

Zsilák S, Gál J, Hodinka L, Rajczy K, Balog A, Sipka S, Baráth S, Kapitány A, Zilahi E, Szekanecz Z.

J Rheumatol. 2005 Dec;32(12):2299-302.

PMID:
16331753
11.

Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases.

Polgár A, Falus A, Koó E, Ujfalussy I, Seszták M, Szuts I, Konrád K, Hodinka L, Bene E, Mészáros G, Ortutay Z, Farkas E, Paksy A, Buzás EI.

Rheumatology (Oxford). 2003 Apr;42(4):522-7.

12.
13.

Cyclosporin and sulfasalazine combination in the treatment of early rheumatoid arthritis.

Rojkovich B, Hodinka L, Bálint G, Szegedi G, Varjú T, Tamási L, Molnár E, Szilágyi M, Szocsik K.

Scand J Rheumatol. 1999;28(4):216-21.

PMID:
10503557
14.

[Fatal myocardial lesion in systemic lupus erythematosus].

Rojkovich B, Kiss G, Bély M, Balogh Z, Hodinka L.

Orv Hetil. 1993 Aug 22;134(34):1869-74. Hungarian.

PMID:
8355978
15.

Improving the risk-benefit ratio of NSAID therapy in the elderly.

Hodinka L.

Scand J Rheumatol Suppl. 1991;91:3-8. Review.

PMID:
1771394
16.

[Defects in opsonization activity of the serum of patients with chronic arthritis].

Böhm U, Merétey K, Seszták M, Hodinka L, Koó E, Zahumenszky Z.

Z Rheumatol. 1988 May-Jun;47(3):161-5. German.

PMID:
3213263
17.
18.
19.

[Comparative study of blood and synovial fluid levels and other parameters of beta-2-microglobulin in rheumatoid arthritis and arthrosis].

Falus A, Merétey K, Böhm U, Hodinka L, Genti G, Bozsóky S.

Orv Hetil. 1982 Apr 18;123(16):977-81. Hungarian. No abstract available.

PMID:
6176927
20.

Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies.

Hodinka L, Géher P, Merétey K, Gyódi EK, Petrányi GG, Bozsóky S.

Int Arch Allergy Appl Immunol. 1981;65(4):460-4.

PMID:
7251195
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk